OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
Bilal Abdulmawjood, Beatriz Costa, Catarina Roma‐Rodrigues, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12516-12516
Open Access | Times Cited: 28
Bilal Abdulmawjood, Beatriz Costa, Catarina Roma‐Rodrigues, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12516-12516
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia
Gustavo P. Amarante‐Mendes, Aamir Rana, Tarcila Santos Datoguia, et al.
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 215-215
Open Access | Times Cited: 57
Gustavo P. Amarante‐Mendes, Aamir Rana, Tarcila Santos Datoguia, et al.
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 215-215
Open Access | Times Cited: 57
Smart biocathodic double signal amplification design empowered self-powered bioplatform ultrasensitive detection of tumor biomarker
Jinyue Shi, Futing Wang, Yeyu Wu, et al.
Sensors and Actuators B Chemical (2023) Vol. 394, pp. 134392-134392
Closed Access | Times Cited: 11
Jinyue Shi, Futing Wang, Yeyu Wu, et al.
Sensors and Actuators B Chemical (2023) Vol. 394, pp. 134392-134392
Closed Access | Times Cited: 11
Chronic myeloid leukemia with the e13a3 atypical fusion gene: A case report
Xin Zhou, Mengran Li, Ning‐ning Shan
Oncology Letters (2025) Vol. 29, Iss. 6, pp. 1-5
Open Access
Xin Zhou, Mengran Li, Ning‐ning Shan
Oncology Letters (2025) Vol. 29, Iss. 6, pp. 1-5
Open Access
Predictive genomic tools in disease stratification and targeted prevention: a recent update in personalized therapy advancements
Neha Jain, Upendra Nagaich, Manisha Pandey, et al.
The EPMA Journal (2022) Vol. 13, Iss. 4, pp. 561-580
Open Access | Times Cited: 13
Neha Jain, Upendra Nagaich, Manisha Pandey, et al.
The EPMA Journal (2022) Vol. 13, Iss. 4, pp. 561-580
Open Access | Times Cited: 13
Molecular Evaluation of the Impact of Polymorphic Variants in Apoptotic (Bcl-2/Bax) and Proinflammatory Cytokine (TNF-α/IL-8) Genes on the Susceptibility and Progression of Myeloproliferative Neoplasms: A Case-Control Biomarker Study
Mamdoh S. Moawadh, Rashid Mir, Faris J. Tayeb, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 5, pp. 3933-3952
Open Access | Times Cited: 7
Mamdoh S. Moawadh, Rashid Mir, Faris J. Tayeb, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 5, pp. 3933-3952
Open Access | Times Cited: 7
Role of Genomics and Proteomics in Drug Discovery
Jeevandran Sundarasekar, Geethaa Sahgal
(2024), pp. 207-246
Closed Access | Times Cited: 2
Jeevandran Sundarasekar, Geethaa Sahgal
(2024), pp. 207-246
Closed Access | Times Cited: 2
Clinical pharmacokinetics and drug–drug interactions of tyrosine-kinase inhibitors in chronic myeloid leukemia: A clinical perspective
Fang Cheng, Hongxiang Wang, Weiming Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 195, pp. 104258-104258
Closed Access | Times Cited: 2
Fang Cheng, Hongxiang Wang, Weiming Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 195, pp. 104258-104258
Closed Access | Times Cited: 2
Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia
Carmela Gómez, Rósula García‐Navas, Fernando C. Baltanás, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3893-3893
Open Access | Times Cited: 8
Carmela Gómez, Rósula García‐Navas, Fernando C. Baltanás, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3893-3893
Open Access | Times Cited: 8
Exploring RAB11A Pathway to Hinder Chronic Myeloid Leukemia-Induced Angiogenesis In Vivo
Catarina Roma‐Rodrigues, Alexandra R. Fernandes, Pedro V. Baptista
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 742-742
Open Access | Times Cited: 4
Catarina Roma‐Rodrigues, Alexandra R. Fernandes, Pedro V. Baptista
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 742-742
Open Access | Times Cited: 4
Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia
Rachid Lahlil, Anne Aries, Maurice Scrofani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16671-16671
Open Access | Times Cited: 4
Rachid Lahlil, Anne Aries, Maurice Scrofani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16671-16671
Open Access | Times Cited: 4
Enabling biomedical technologies for chronic myelogenous leukemia (CML) biomarkers detection
Meenakshi Pinnenti, Muhammad Ahsan Sami, Umer Hassan
Biomicrofluidics (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Meenakshi Pinnenti, Muhammad Ahsan Sami, Umer Hassan
Biomicrofluidics (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
An Overview of Myeloid Blast-Phase Chronic Myeloid Leukemia
Gulsum E. Pamuk, Lori A. Ehrlich
Cancers (2024) Vol. 16, Iss. 21, pp. 3615-3615
Open Access | Times Cited: 1
Gulsum E. Pamuk, Lori A. Ehrlich
Cancers (2024) Vol. 16, Iss. 21, pp. 3615-3615
Open Access | Times Cited: 1
An overview about biomarkers in breast cancer: Insights into the diagnostic and prognostic significance
Vanessa Emanuelle Pereira Santos, Pedro Luiz de França Neto, Beatriz Eda de Oliveira Isídio, et al.
Clinica Chimica Acta (2024) Vol. 567, pp. 120030-120030
Closed Access | Times Cited: 1
Vanessa Emanuelle Pereira Santos, Pedro Luiz de França Neto, Beatriz Eda de Oliveira Isídio, et al.
Clinica Chimica Acta (2024) Vol. 567, pp. 120030-120030
Closed Access | Times Cited: 1
Activation of ERK1 /2 by MOS and TPL2 leads to dasatinib resistance in chronic myeloid leukaemia cells
Masanobu Tsubaki, Tomoya Takeda, Yuuichi Koumoto, et al.
Cell Proliferation (2023) Vol. 56, Iss. 6
Open Access | Times Cited: 3
Masanobu Tsubaki, Tomoya Takeda, Yuuichi Koumoto, et al.
Cell Proliferation (2023) Vol. 56, Iss. 6
Open Access | Times Cited: 3
PARP1 Characterization as a Potential Biomarker for BCR::ABL1 p190+ Acute Lymphoblastic Leukemia
Caio Bezerra Machado, Emerson Lucena da Silva, Wallax Augusto Silva Ferreira, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5510-5510
Open Access | Times Cited: 1
Caio Bezerra Machado, Emerson Lucena da Silva, Wallax Augusto Silva Ferreira, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5510-5510
Open Access | Times Cited: 1
Polymorphisms in Drug Transporter and Metabolism Genes Associated with Resistance to Imatinib in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis
Ana Marcela Arrieta Gómez, María Antonia Díaz-Mendoza, Yesit Bello-Lemus, et al.
Scientia Pharmaceutica (2023) Vol. 92, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
Ana Marcela Arrieta Gómez, María Antonia Díaz-Mendoza, Yesit Bello-Lemus, et al.
Scientia Pharmaceutica (2023) Vol. 92, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
The role of gene expression hypoxia-inducible factor-1a and serum level monocyte chemoattractant protein-1 in the incidence of chronic myeloid leukemia in Iraqi patients
Noor Tariq Naeem, Basima Qasim Hasan Alsaadi
Iraqi Journal of Hematology (2024) Vol. 13, Iss. 1, pp. 50-58
Open Access
Noor Tariq Naeem, Basima Qasim Hasan Alsaadi
Iraqi Journal of Hematology (2024) Vol. 13, Iss. 1, pp. 50-58
Open Access
Impact of MDR-1 Gene Polymorphism (rs1128503) on Response to Imatinib or Nilotinib in Iraqi Patients with Chronic Myeloid Leukemia: An Observational Study
Ekhlas Khammas Hasan, Ali A. Kasim, Bassam Francis Matti
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2024) Vol. 6, Iss. 1, pp. 215-221
Open Access
Ekhlas Khammas Hasan, Ali A. Kasim, Bassam Francis Matti
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2024) Vol. 6, Iss. 1, pp. 215-221
Open Access
Association of PARP1 Expression Levels and Clinical Parameters in Different Leukemic Subtypes With BCR::ABL1 p190+ Translocation
GUILHERME PASSOS DE MORAIS, Caio Bezerra Machado, Beatriz Maria Dias Nogueira, et al.
Cancer Diagnosis & Prognosis (2024) Vol. 4, Iss. 5, pp. 592-598
Open Access
GUILHERME PASSOS DE MORAIS, Caio Bezerra Machado, Beatriz Maria Dias Nogueira, et al.
Cancer Diagnosis & Prognosis (2024) Vol. 4, Iss. 5, pp. 592-598
Open Access
Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia
Jingwei Zhao, Guiran Wang, Guiling Yan, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Jingwei Zhao, Guiran Wang, Guiling Yan, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
A novel LL-37@NH2@Fe3O4 inhibits the proliferation of the leukemia K562 cells: in-vitro study
Alireza Habibi, Aynaz Davari, K H Isazadeh
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Alireza Habibi, Aynaz Davari, K H Isazadeh
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Investigating the role of non-synonymous variant D67N of ADGRE2 in chronic myeloid leukemia
Ayesha Afzal, Humzah Jamshaid, Yasmin Badshah, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Ayesha Afzal, Humzah Jamshaid, Yasmin Badshah, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Cytogenetic profile of leukemia cases in northern region of Malaysia - A single centre retrospective study
Nur Haida Natasha Shamsuddin, Abdul Rahman Azhari, Muhamad Amir Azizan, et al.
Asia-Pacific Journal of Molecular Biology and Biotechnology (2024), pp. 46-54
Open Access
Nur Haida Natasha Shamsuddin, Abdul Rahman Azhari, Muhamad Amir Azizan, et al.
Asia-Pacific Journal of Molecular Biology and Biotechnology (2024), pp. 46-54
Open Access
Application of Drug Repurposing-Based Precision Medicine Platform for Leukaemia Patient Treatment
Vanelle Larissa Kenmogne, Ekene Emmanuel Nweke, Mutsa M. Takundwa, et al.
Advances in experimental medicine and biology (2022), pp. 115-126
Closed Access | Times Cited: 1
Vanelle Larissa Kenmogne, Ekene Emmanuel Nweke, Mutsa M. Takundwa, et al.
Advances in experimental medicine and biology (2022), pp. 115-126
Closed Access | Times Cited: 1
Integrated Chemical Characterization, Network Pharmacology and Transcriptomics to Explore the Mechanism of Sesquiterpenoids Isolated from Gynura divaricata (L.) DC. against Chronic Myelogenous Leukemia
Xinyuan Ye, Long Wang, Xin Yang, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1435-1435
Open Access | Times Cited: 1
Xinyuan Ye, Long Wang, Xin Yang, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1435-1435
Open Access | Times Cited: 1
